Pierre M Bet
Overview
Explore the profile of Pierre M Bet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
408
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
En-Nasery-de Heer S, Uitvlugt E, Bet P, van den Bemt B, Alai A, Van den Bemt P, et al.
J Clin Pharm Ther
. 2022 Mar;
47(7):1049-1069.
PMID: 35306683
What Is Known And Objective: The recently conducted Medication Actions to Reduce hospital admissions through a collaboration between Community and Hospital pharmacists (MARCH) transitional care programme, which aimed to test...
12.
Atmowihardjo L, Schippers J, Bartelink I, Bet P, van Rein N, Purdy K, et al.
Trials
. 2022 Feb;
23(1):158.
PMID: 35172891
Background: The coronavirus disease 2019 (COVID-19) pandemic has led to a disruptive increase in the number of intensive care unit (ICU) admissions with acute respiratory distress syndrome (ARDS). ARDS is...
13.
Middelkoop M, de Lange M, Clark T, Mol B, Bet P, Huirne J, et al.
Hum Reprod
. 2022 Feb;
37(5):884-894.
PMID: 35143669
Ulipristal acetate (UPA) is a medical treatment for uterine fibroids and was authorized for surgical pre-treatment in 2012 after the conduct of the PEARL I and II randomized controlled trials...
14.
Bartelink I, Bet P, Widmer N, Guidi M, Duijvelaar E, Grob B, et al.
CPT Pharmacometrics Syst Pharmacol
. 2021 Oct;
10(12):1497-1511.
PMID: 34608769
This study aimed to determine whether published pharmacokinetic (PK) models can adequately predict the PK profile of imatinib in a new indication, such as coronavirus disease 2019 (COVID-19). Total (bound...
15.
Rusman T, van der Weijden M, Nurmohamed M, van der Bijl C, van der Laken C, Bet P, et al.
Arthritis Rheumatol
. 2021 Jun;
73(12):2352-2353.
PMID: 34180159
No abstract available.
16.
Aman J, Duijvelaar E, Botros L, Kianzad A, Schippers J, Smeele P, et al.
Lancet Respir Med
. 2021 Jun;
9(9):957-968.
PMID: 34147142
Background: The major complication of COVID-19 is hypoxaemic respiratory failure from capillary leak and alveolar oedema. Experimental and early clinical data suggest that the tyrosine-kinase inhibitor imatinib reverses pulmonary capillary...
17.
Uitvlugt E, En-Nasery-de Heer S, van den Bemt B, Bet P, Sombogaard F, Hugtenburg J, et al.
Res Social Adm Pharm
. 2021 May;
18(4):2651-2658.
PMID: 34049802
Introduction: Transitional care programs (i.e. interventions delivered both in hospital and in primary care), could increase continuity and consequently quality of care. However, limited studies on the effect of these...
18.
van Merendonk L, Leeuwerik A, den Brok M, Hekking P, Korevaar D, Jacobs C, et al.
Am J Health Syst Pharm
. 2021 May;
78(21):1944-1951.
PMID: 33950198
Purpose: The coronavirus disease 2019 (COVID-19) pandemic resulted in accelerated market access to remdesivir worldwide. Therefore, data about complications experienced during use of the drug are limited. This is the...
19.
Ganesh S, Beunk L, Nikolik B, van der Weide J, Bet P
Ther Drug Monit
. 2021 Feb;
43(5):672-680.
PMID: 33560096
Background: Interpatient variability in cytochrome P450 2D6 (CYP2D6) enzyme activity alters the serum concentrations of most psychotropics, which often have narrow therapeutic indices. Therefore, preemptive knowledge of CYP2D6 activity is...
20.
Middelkoop M, Bet P, Drenth J, Huirne J, Hehenkamp W
Br J Clin Pharmacol
. 2020 Dec;
87(7):2685-2697.
PMID: 33341097
Aims: Uterine fibroids are benign tumours that cause various complaints. These complaints may significantly compromise quality of life, necessitating a clinical intervention in 25-50% of the affected women. Hysterectomy, myomectomy...